Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Biohaven licenses therapeutic antibody from University of Connecticut

Oct. 10, 2018

Neurocrine Biosciences and Jnana collaborate to treat CNS disorders

Oct. 10, 2018

Amicus and University of Pennsylvania establish gene therapy collaboration

Oct. 9, 2018

Acurx and WuXi collaborate to advance the development of first-in-class antibiotics

Oct. 9, 2018

Calithera Biosciences enters collaboration with Pfizer for combination studies of CB-839

Oct. 8, 2018

Cyclacel Pharmaceuticals forms alliance with MD Anderson Cancer Center

Oct. 8, 2018

Celyad enters agreement to use Horizon Discovery's shRNA technology

Oct. 5, 2018

Eagle enters agreement with USAMRICD to evaluate neuroprotective effects of Ryanodex

Oct. 4, 2018

Boston expands pipeline through licensing deals with Novartis and GSK

Oct. 4, 2018

Go Therapeutics and Roche enter license agreement to develop glycotargeting bispecific antibody

Oct. 4, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...